What we're reading, February 3, 2016: President Obama is asking Congress for $1.1 billion to combat the opioid abuse epidemic; 7 blockbuster drugs with the potential for more than $1 billion in sales each are expected in 2016; and less than half of infants are vaccinated against the flu.
The Obama administration is seeking $1.1 billion from Congress to combat the growing opioid abuse epidemic. The New York Times reported that half of the new money would expand treatment facilities, while the other half would go to programs intended to prevent overdoses and illegal sales, as well as improve access to naloxone, which can reverse the effects of an overdose. Both Republican and Democratic presidential candidates—including Republicans Chris Christie and Ben Carson, and Democrat Hillary Clinton—have spoken out about addressing the growing epidemic of prescription painkiller abuse.
In 2016, 7 “blockbuster” drugs are expected to reach market. Reuters reported that each drug is projected to have the potential for more than $1 billion in sales. The 2 biggest treatments anticipated are Intercept Pharmaceuticals’ chronic liver disease drug, and Gilead Sciences’ new fixed dose HIV drug. In 2015, there were 11 new blockbuster drugs.
Among babies between the ages of 6 months and 23 months, less than half are getting the flu vaccine, CDC reported. While the number of infants being vaccine has increased sharply from less than 5% in 2002-2003 to almost 45% in 2011-2012, the total still falls short of the CDC’s recommendation that children age 6 months and older get the flu shot every year, according to HealthDay. Every year, 20,000 children under the age of 5 years are hospitalized because of complications from the flu and during the 2014-2015 flu season, more than 140 children died from the flu.
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More